Kenneth J. Bender, PharmD, MA

A PAINWeek 2016 expert panel gave attendees behind-the-scenes insight into the process behind the CDC's final recommendations.

At PAINWeek 2016, a session on abuse-deterrent formulations underscored that this drug class will never be free from abuse potential.

A PAINWeek audience experienced behavioral Rx during a presentation on effective non-drug treatment for migraine.

This PAINWeek 2016 presentation focused on how to more deeply involve patients in their own pain management plan.

Different strategies to prompt patients to take their antidepressant as prescribed have been tried. Many that have been evaluated in controlled trials are considered in a new review that examines their effectiveness.